Growth Metrics

BeOne Medicines (ONC) Accounts Payables: 2015-2024

Historic Accounts Payables for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $405.0 million.

  • BeOne Medicines' Accounts Payables rose 24.76% to $383.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $383.7 million, marking a year-over-year increase of 24.76%. This contributed to the annual value of $405.0 million for FY2024, which is 28.53% up from last year.
  • As of FY2024, BeOne Medicines' Accounts Payables stood at $405.0 million, which was up 28.53% from $315.1 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Accounts Payables ranged from a high of $405.0 million in FY2024 and a low of $232.0 million during FY2020.
  • Over the past 3 years, BeOne Medicines' median Accounts Payables value was $315.1 million (recorded in 2023), while the average stood at $338.3 million.
  • Data for BeOne Medicines' Accounts Payables shows a peak YoY skyrocketed of 89.37% (in 2020) over the last 5 years.
  • BeOne Medicines' Accounts Payables (Yearly) stood at $232.0 million in 2020, then climbed by 13.12% to $262.4 million in 2021, then grew by 12.34% to $294.8 million in 2022, then rose by 6.90% to $315.1 million in 2023, then climbed by 28.53% to $405.0 million in 2024.